CH
EXAS

Canton Hathaway’s Exact Sciences EXAS Stock Holding History

Canton Hathaway’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,000
Closed -$191K – 300
2021
Q3 		$191K Hold
2,000
– – 0.05% 113
2021
Q2 		$249K Buy
+2,000
New +$239K 0.07% 95
2020
Q3 		– Sell
-1,550
Closed -$135K – 283
2020
Q2 		$135K Hold
1,550
– – 0.09% 77
2020
Q1 		$90K Buy
+1,550
New +$126K 0.06% 82

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Canton Hathaway's EXAS Position: Q4 2021 in Review

Canton Hathaway sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 2,000 shares — an estimated $191K sold.

Canton Hathaway first reported a position in EXAS in Q1 2020 and held it in 4 quarters. The position peaked at $249K in Q2 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Canton Hathaway reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Canton Hathaway sold 2,000 Exact Sciences shares in Q4 2021, an estimated $191K.
  • Canton Hathaway first reported a position in Exact Sciences in Q1 2020 and held it in 4 quarters.
  • Canton Hathaway's Exact Sciences position peaked at $249K in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Canton Hathaway's 13F filing for Q4 2021, filed 6 Jan 2022.